전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,016 programs
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD19-BAFF Targeted CAR T-cells (CD19-BAFF Targeted CAR T-cells)

Acute Lymphoblastic Leukemia,B-Cell; Non-hodgkin Lymphoma,B Cell · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 2Status Recruiting
CGTLimited DatastaleOneChain ImmunotherapeuticsPhase 1

CD1a-CAR T (CD1a-CAR T)

T-cell Acute Lymphoblastic Leukemia; Lymphoblastic T-Cell Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleGyala TherapeuticsPhase 1

CD84-CART (CD84-CART)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleFrontiergate Biopharm（Hainan） C…Phase 1

Claudin18.2-targeted CAR-DCs (Claudin18.2-targeted CAR-DCs)

Colorectal Neoplasia · Colorectal Neoplasia

#ColorectalNeoplasia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
AntibodyLimited DatastaleMerckPhase 2

pembrolizumab (Keytruda, Coformulated vibostolimab/pembrolizumab)

Metastatic Urothelial Carcinoma; Urothelial Neoplasms · Metastatic Urothelial Carcinoma

#MetastaticUrothelialCarcinoma#Antibody#Phase2#monoclonal-antibody#UrothelialNeoplasms+1
Trials 2Status Recruiting
AntibodyLimited DatastaleHoffmann-La RocheApproved

Daclizumab (Daclizumab)

Type 1 Diabetes Mellitus · Myelodysplastic Syndromes

#MyelodysplasticSyndromes#Antibody#Approved#monoclonal-antibody#Type1DiabetesMellitus+1
Trials 2Status Active
AntibodyLimited DatastaleMerck Sharp & Dohme LLCPhase 2

Dalotuzumab (Dalotuzumab)

Rectal Neoplasms · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#monoclonal-antibody#Merck
Trials 2Status Active
CGTLimited DatastaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleImmune Design, a subsidiary of …Phase 1

Dendritic Cell-targeting Lentiviral Vector ID-LV305 (Dendritic Cell-targeting Lentiviral Vector ID-LV305)

HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present · HLA-A*0201 Positive Cells Present

#HLA-A0201PositiveCellsPresent#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Active
AntibodyLimited DatastaleNovartisPhase 3

Experimental: Secukinumab high dose (Experimental: Secukinumab high dose)

Chronic Severe Plaque-type Psoriasis · Chronic Severe Plaque-type Psoriasis

#ChronicSeverePlaque-typePsoriasi#Antibody#Phase3#monoclonal-antibody#Novartis
Trials 2Status Active
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

GD2, PSMA and CD276 CAR-T cells (GD2, PSMA and CD276 CAR-T cells)

Neuroblastoma · PSMA

#PSMA#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleBambino Gesù Hospital and Resea…Phase 2

GD2-CART01 (GD2-CART01)

Neuroblastoma; Neuroblastoma Recurrent · GD2

#GD2#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleStanford UniversityPhase 1

GPC2-CAR T cells (GPC2-CAR T cells)

Medulloblastoma; Central Nervous System Embryonal Tumor · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

HF10 plus Ipilimumab (HF10 plus Ipilimumab)

Malignant Melanoma · Malignant Melanoma

#MalignantMelanoma#Antibody#Phase2#monoclonal-antibody#Bristol
Trials 2Status Active
CGTLimited DatastaleBristol-Myers SquibbPhase 1

IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells)

Metastatic Malignant Solid Neoplasm; Metastatic Melanoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
AntibodyLimited DatastaleJanssenPhase 1

daratumumab (Darzalex, Indium In 111-DOTA-Daratumumab)

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia · FRα

#FR#Antibody#Phase1#monoclonal-antibody#AcuteLymphoblasticLeukemia+2
Trials 2Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

CD19+ Malignancies: Relapse Post-allogeneic Transplant · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleMinicirclePhase 1

Injectable Plasmid Klotho Gene Therapy (Injectable Plasmid Klotho Gene Therapy)

Healthy Adults · Healthy Adults

#HealthyAdults#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
AntibodyLimited DatastaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (Iparomlimab and Tuvonralimab Injection, Iparomlimab and Tuvonralimab Injection (QL1706))

Hepatocellular Carcinoma (HCC); Immunotherapy · Hepatecellular Carcinoma

#HepatecellularCarcinoma#Antibody#Phase2#monoclonal-antibody#HepatocellularCarcinomaHCC+2
Trials 2Status Recruiting
CGTLimited DatastaleRenJi HospitalPhase 1

JWCAR201 (JWCAR201)

Diffuse Large B Cell Lymphoma · B-cell Tumors

#B-cellTumors#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting

17 / 51 pages

← PreviousNext →